載入...
The risk of febrile neutropenia in breast cancer patients following adjuvant chemotherapy is predicted by the time course of interleukin‐6 and C‐reactive protein by modelling
AIMS: Early identification of patients with febrile neutropenia (FN) is desirable for initiation of preventive treatment, such as with antibiotics. In this study, the time courses of two inflammation biomarkers, interleukin (IL)‐6 and C‐reactive protein (CRP), following adjuvant chemotherapy of brea...
Na minha lista:
| 發表在: | Br J Clin Pharmacol |
|---|---|
| Main Authors: | , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
John Wiley and Sons Inc.
2018
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5809342/ https://ncbi.nlm.nih.gov/pubmed/29178353 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.13477 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|